The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
Open accessAbstract
Alzheimer's disease (AD) is a major contributor of dementia leading to the degeneration of neurons in the brain with major symptoms like loss of memory and learning. Many evidences suggest the involvement of neuroinflammation in the pathology of AD. Cytokines including TNF-α and IL-6 are also found increasing the BACE1 activity and expression of NFκB resulting in generation of Aβ in AD brain. Following the interaction of Aβ with microglia and astrocytes, other inflammatory molecules also get translocated to the site of inflammation by chemotaxis and exaggerate neuroinflammation. Various pathways like NFκB, p38 MAPK, Akt/mTOR, caspase, nitric oxide and COX trigger microglia to release inflammatory cytokines. PPARγ agonists like pioglitazone increases the phagocytosis of Aβ and reduces inflammatory cytokine IL-1β. Celecoxib and roficoxib like selective COX-2 inhibitors also ameliorate neuroinflammation. Non-selective COX inhibitor indomethacin is also potent inhibitor of inflammatory mediators released from microglia. Mitophagy process is considered quite helpful in reducing inflammation due to microglia as it promotes the phagocytosis of over activated microglial cells and other inflammatory cells. Mitophagy induction is also beneficial in the removal of damaged mitochondria and reduction of infiltration of inflammatory molecules at the site of accumulation of the damaged mitochondria. Targeting these pathways and eventually ameliorating the activation of microglia can mitigate neuroinflammation and come out as a better therapeutic option for the treatment of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several pathological factors in AD, such as Aβ, pro-inflammatory cytokines, and oxidative stress, activate microglia and initiate downstream signaling pathways such as MAPK, NF-κB, and PI3K/Akt.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The activation of these pathways further promotes the activation of microglia and the production of inflammatory mediators, exacerbating neurotoxicity.238–240”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [240]
The cited source says what the claim attributes to it.
In the citing paper
“A significant trigger for astrocyte reactivity is neuroinflammation, involving pro-inflammatory molecules like cytokines and chemokines (11–14).”
From Varicose projection astrocytes: Conserved reactive cells in brain pathology (2026) · cites this paper as [12]
In the citing paper
“A growing amount of evidence has revealed that a sustained inflammatory state in the brain is a major contributor in the AD pathogenesis (Dhapola et al., 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Dhapola et al., 2021
In the citing paper
“Neuroinflammation has been identified as a key contributor to the pathobiology of AD [2–4]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, H.-Y., Lee, K.-C., Pei, Z., Khan, A., Bakshi, K. P., & Burns, L. H. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.016 · Cited by 48
Retracted2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461 · cited 1×
“Gradually the person becomes bedridden and ultimately leads to death of the Alzheimer’s Association (2019).”
BackgroundNeuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
Alzheimer's disease drug development pipeline: 2018
Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697
Neuroinflammation pathways: a general review
Shabab, T., Khanabdali, R., Moghadamtousi, S. Z., Kadir, H. A., & Mohan, G. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1212854 · Cited by 657
The Alzheimer’s Disease Clinical Spectrum
Atri, A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.009 · Cited by 623
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Aging and Alzheimer's disease pathology
Sengoku, R. (2019) · Neuropathology · doi:10.1111/neup.12626 · Cited by 316
Cited by
Sorted by citations
Items 201–300 of 383
Zhu, Q., Song, Y., Qian, Y., Zhang, R., Xue, J., & Hou, Y. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.25 · Cited by 6
Zhang, R.-Z., Li, L., Ma, C., Dou, T., Wei, Y.-T., & Yan, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s557000 · Cited by 6
Mild cognitive impairment in type 2 diabetes is associated with fibrinogen-to-albumin ratios
Li, X., Wu, Q., Kong, Y., & Lu, C. (2023) · PeerJ · doi:10.7717/peerj.15826 · Cited by 7
Zhang, B., Deng, L. Q., Liu, X., Hu, Y., Wang, W., Li, M., Xu, T., Pang, L., & Lv, M. (2024) · Neurological Research · doi:10.1080/01616412.2024.2337517 · Cited by 7
Xia, N., Xu, L., Huang, M., Xu, D., Li, Y., Wu, H., Mei, Z., & Yu, Z. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176638 · Cited by 7
Microglia-Associated Neuroinflammation in Alzheimer’s Disease and Its Therapeutic Potential
Shah, S., & Jain, H. (2024) · Neuroglia · doi:10.3390/neuroglia5040029 · Cited by 10
Ran, Q., Gao, C., Xiang, C., He, X., Zhang, Y., Zhang, Y., & Chen, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1646072 · Cited by 8
Air pollution as a key risk factor for alzheimer’s disease: A comprehensive review
Zhu, X., Guo, C., Zhang, Y., & Wei, Y. (2025) · Environmental Technology & Innovation · doi:10.1016/j.eti.2025.104555 · Cited by 6
Exercise mimetics: molecular mechanisms, biological and therapeutic effects
Zhang, J., Shao, Q., 程腾, Lin, J., Tang, Y., Lu, H., Zhang, Y., Yu, Z., & Cao, L. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00483-8 · Cited by 8
Nanoneuroscience: Cutting-edge Approach for Disease Management
Malhotra, S., Jain, N., Rathee, J., Kaul, S., Nagaich, U., Pandey, M., Gorain, B., & Gupta, G. (2023) · Recent Patents on Nanotechnology · doi:10.2174/1872210517666230403105152 · Cited by 6
Xu, Y., Zhang, J., & Li, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1328334 · Cited by 7
Chen, H., Chang, X., Zhou, J., Zhang, G., Cheng, J., Zhang, Z., Xing, J., Yan, C., & Liu, Z. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273337232241121113048 · Cited by 6
Neuroinflammation and Reconsolidation of Memory
Grigoryan, G. A. (2022) · Neurochemical Journal · doi:10.1134/s1819712422020076 · Cited by 6
A delay in vesicle endocytosis by a C-terminal fragment of N-cadherin enhances Aβ synaptotoxicity
Teng, Z., Kartalou, G.-I., Dagar, S., Fraering, P. C., Leßmann, V., & Gottmann, K. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01739-w · Cited by 6
Molecular interplay between phytoconstituents of Ficus Racemosa and neurodegenerative diseases
Rani, A., Sabah, Z. U., Tabassum, F., & Sharma, A. K. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16250 · Cited by 6
Liu, C., Liao, Y., Jiang, H., Tang, Q., He, C., Wang, Y., Ren, M., Wang, C., Chen, S., Tan, L., et al. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116185 · Cited by 5
Liao, H., Wang, X., Yang, C., Wang, Z., Liu, X., Liu, H., Zhang, J., Shen, H., & Wang, H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115328 · Cited by 5
CircRNA-Based Therapeutics: a New Frontier in Neuroinflammation Treatment
Muhammed, T. M., Jasim, S. A., Uthirapathy, S., Mandaliya, V. B., Ballal, S., Kalia, R., Arya, R., Nakash, P., Mustafa, Y. F., & Ahmed, J. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05258-w · Cited by 5
Fei, L., Chen, H., Zhao, M., Wu, M., Lin, Q., Shen, T., Tong, L., Xu, X., Liu, X., Mi, B., et al. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.08.018 · Cited by 5
Teng, Y., Xu, J., He, S., Yi, J., Li, M., Tang, Q., Chen, X., Wei, F., Liu, Y., Jiang, H., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03211-w · Cited by 5
Research progress of exosomes used in the Alzheimer's disease treatment
Gao, X., Yang, K., Yuan, X., Song, M., Wang, T., & Shen, C. (2025) · Discover Nano · doi:10.1186/s11671-025-04361-0 · Cited by 6
Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease
Tian, M., Zhang, Y., Yuan, Y., Li, H., & He, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-02297-w · Cited by 7
Wen, Y., Zeng, X., Luo, H., Cheng, Y., Xing, J., Zhao, H., & Chen, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143029 · Cited by 5
Chaudhary, S., Rawat, S., Mathur, S., Perveen, A., Hafeez, A., Bilgrami, A. L., & Ashraf, G. M. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2520707 · Cited by 5
Pei, M.-Q., Xu, L., Yang, Y.-S., Chen, W.-C., Chen, X.-L., Fang, Y.-M., Lin, S., & He, H. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148821 · Cited by 6
He, R. Q., Cheng, J., Qiu, Y., Hu, Y., Liu, J., Wang, T., & Cao, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112512 · Cited by 6
Liu, W., Rao, X., Sun, W., Chen, X., Yu, L., Zhang, J., Chen, J., & Zheng, X. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05164-0 · Cited by 6
Linzhu, Zhang, J., Fan, W., Su, C., & Jin, Z. (2025) · BMC Neurology · doi:10.1186/s12883-025-04057-z · Cited by 6
Kumar, K., Aggarwal, S., Kandpal, A., Kaur, R., Jaggi, A. S., Yadav, H. N., Singh, D., Chopra, D., & Singh, N. (2025) · Experimental Brain Research · doi:10.1007/s00221-025-07072-1 · Cited by 5
Nesfatin-1 ameliorates pathological abnormalities in Drosophila hTau model of Alzheimer's disease
Yang, J., Baek, S.-E., Yoon, J.-W., Kim, H., Kwon, Y., & Yeom, E. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150311 · Cited by 5
Varicose-projection astrocytes: a reactive phenotype associated with neuropathologyPreprint
Ciani, C., Pistorio, G., Giancola, S., Mearelli, M., Mongelli, F. E., Forouzeh, D., Mio, L., Ramos‐Gonzalez, P., Matute, C., Kuliešiūtė, U., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.17.643488 · Cited by 5
Varicose projection astrocytes: Conserved reactive cells in brain pathology
Ciani, C., Pistorio, G., Giancola, S., Mearelli, M., Mongelli, F. E., Forouzeh, D., Campos Soares, L., Gonzalez Martin, M., Lichtenstein, M. E., Mio, L., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady8204 · Cited by 4
Novel targets for treating neurodegenerative diseases: The PKM2-STAT3-hnRNPA1 feedback loop
Ye, P., Li, Z., & Jiang, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107840 · Cited by 4
Jazuli, I., Hing, G. B., Selvaratnam, L., Han, L. L., Alex, D., & Kumari, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105764 · Cited by 4
Chakraborty, S., & Sinha, A. (2023) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v11i4.1302 · Cited by 4
Teerapattarakan, N., Kamsrijai, U., Janyou, A., Hankittichai, P., Anukanon, S., Hawiset, T., & Issara, U. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.03.014 · Cited by 4
Fan, X., Diao, W., Wang, H., Yin, X., & Qian, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072906 · Cited by 5
Yao, M., Liu, A., Song, J., Xing, L., Huang, Y., & Li, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149852 · Cited by 4
He, Y., Li, K., Wu, Y., Jin, Z., Hu, J., Mao, Y., & Xiong, J. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60929-0 · Cited by 4
Akaishi, T., Yamamoto, S., & Abe, K. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00033 · Cited by 4
Maxwell, J. R., Noor, S., Pavlik, N. G., Rodriguez, D. E., Marquez, L. E., DiDomenico, J., Blossom, S. J., & Bakhireva, L. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137019 · Cited by 4
de Lima, B. R. F., Patriota, L. L. D. S., Marinho, A. D. O., da Costa, J. A., Ribeiro, B. G., Santos, V. B. D. S., Napoleão, D. C., Cavalcanti, J. V. F. L., Filho, L. D. V., Pereira, M. C., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119343 · Cited by 4
Ni, W., Ding, J., Gong, P., Tan, X., & Li, J. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105936 · Cited by 4
Örs, H., Alimoğulları, E., Erdem, S. A., Elmazoğlu, Z., & Ceylan‐Isik, A. F. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70073 · Cited by 4
Fu, R.-N., Lian, W., Zhang, B.-H., Liu, G., Feng, X.-Y., Zhu, Y.-J., Zhou, J.-A., Zhang, X.-Y., Wang, S.-K., Huo, H.-J., et al. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s481649 · Cited by 2
da Silva, E. A., Faber, J., Penitente, A. R., Fernandes, J., Bertolucci, P. H. F., Longo, B. M., & Arida, R. M. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115217 · Cited by 3
Protective effect and mechanism of Zhuang medicine Tinosporae Radix on LPS-induced neuroinflammation
Wang, J., Xie, Y., Wang, S., Chen, L., Wu, L., Hu, Z., Deng, J., Wu, Z., Wang, Y., Wang, S., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120276 · Cited by 3
Yu, J., Bao, X., Shan, C., Yu, Z., Yu, Y., Wang, H., & Zhang, Y. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1691253 · Cited by 3
ÇELİK, H., Çelik, O., Aydın, Ş., Küçükler, S., Çomaklı, S., Topal, A., Akay, R., Gönüllü, S., Yıldız, M. O., Alım, B., et al. (2026) · Gene · doi:10.1016/j.gene.2026.150014 · Cited by 4
Paidlewar, M., Kumari, S., Dhapola, R., Sharma, P., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.053 · Cited by 3
Self-citationTang, P., Zhao, J., & Tang, L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.04.031 · Cited by 3
The Bright and Dark Sides of Nitric Oxide in Neurodegenerative Diseases
Buccarello, L., Montagna, C., Matteo, S. D., Mangione, R., Carota, G., Sibbitts, J., Jarošová, R., Lunte, S. M., Lazzarino, G., & Caruso, G. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16050246 · Cited by 3
From Molecular Networks to Medicines: Targeting Complexity in Alzheimer’s Disease (AD) Therapy
Kumar, D. R. P., Patel, S., Mishra, P. S., Srivastava, S., Sridhar, S. B., Shareef, J., Sahu, R., Tariq, M., Uddin, J., & Muhsinah, A. B. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05909-6 · Cited by 3
Failed resolution of inflammation in intracerebral haemorrhage
Cao, L., Zhao, W., Zhang, Y., Pi, W., Yong, V. W., & Xue, M. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01227-6 · Cited by 3
OAS1: A Protective Mechanism for Alzheimer’s Disease? An Exploration of Data and Possible Mechanisms
Elsworthy, R. J., Pearce, A., Masoudzadeh, F., Koska, K., Lodhiya, H., Meher, G., Adjej, J., & Brookes, K. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020524 · Cited by 3
Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer´s Disease
Radermacher, J., Erhardt, V. K. J., Walzer, O., Haas, E. C., Kuppler, K. N., Zügner, J. S. R., Lauer, A. A., Hartmann, T., Grimm, H. S., & Grimm, M. O. W. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117969 · Cited by 3
Wang, J., Wang, D.-Z., Li, B.-H., Yang, S., Guo, F., Zheng, B., & Wang, J.-H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251322809 · Cited by 3
Levetiracetam: An antiseizure drug with unique neuroprotective properties
Ewens, A. N., & Thayer, S. A. (2025) · ASPET Discovery · doi:10.1016/j.aspetd.2025.100006 · Cited by 4
Wang, X., Wang, J., Bi, H., Zhang, Z., Zhang, M., & Wang, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144387 · Cited by 3
Cui, J., Xu, L., Sun, Y., Dai, L., Mo, Y., Yun, K., Chen, Y., & Chen, L. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0861 · Cited by 3
Physical exercise and lifestyle management: Preventive measures for Alzheimer's disease
Mishra, P. K., Ghosh, S., Singh, D. K. K., & Sinha, J. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00003-3 · Cited by 3
White Matter Neuroinflammation Matters in Early Alzheimer Disease
Shinotoh, H. (2024) · Neurology · doi:10.1212/wnl.0000000000208090 · Cited by 3
Shiotani, M., Hyohdoh, Y., Hatakeyama, Y., Kazui, H., & Okuhara, Y. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05982-x · Cited by 2
Miao, J., Huang, Y., Yi, Q., Wang, Y., Xiao, S., Liu, Y., Yang, C., Li, X., Li, T., He, K., et al. (2025) · Food & Function · doi:10.1039/d5fo01180a · Cited by 2
Oligodendroglia in Ageing and Age-Dependent Neurodegenerative Diseases
Niu, J., Verkhratsky, A., Butt, A. M., & Yi, C. (2025) · Advances in neurobiology · doi:10.1007/978-3-031-87919-7_13 · Cited by 4
Chronic traumatic encephalopathy
Esin, R. G., Gorobets, E. A., Esin, O. R., & Mashtakova, A. I. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512508116 · Cited by 2
Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects
Rai, S., Nair, A., Saleem, Z., Ray, S. K., Kanwar, J. R., & Mukherjee, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.051 · Cited by 2
Bhatt, K., Jayanthi, N., & Kumar, M. (2025) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-025-01644-9 · Cited by 2
Ozone Saline Solution Polarizes Microglial Cells Towards an Anti-Inflammatory Phenotype
Armeli, F., Mengoni, B., Menin, M., Martı́nez-Sánchez, G., Martinelli, M., Maggiorotti, M., & Businaro, R. (2025) · Molecules · doi:10.3390/molecules30193932 · Cited by 2
Yang, G., Li, J., Guo, J., Liu, Y., Yan, J., Huang, H., Liu, J., Peng, C., Gan, M., & Shu, J. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109098 · Cited by 2
Gouilly, D., Da-Costa, A., Vrillon, A., Pistono, A., Goubeaud, M., Bertrand, E., Germain, J., Ainaoui, N., Bras, S., Catalá, H., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03625-x · Cited by 3
Wang, Y., Zhang, G., Wang, L., Cheng, Z., & Zhao, Z. (2026) · Biological Trace Element Research · doi:10.1007/s12011-025-04928-z · Cited by 2
Yang, D., Liu, L., & Fu, J. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin43410 · Cited by 2
Liu, Z., Liu, S., Chang, Y., & Rong, J. (2026) · European journal of medical research · doi:10.1186/s40001-026-04151-z · Cited by 2
Fonseca, C., Gouveia, F., Silva, S., Castanheira, S., Driouech, L., Matos, A. M., Barbosa, R. M., Camins, A., Falcão, A. C., Ettcheto, M., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119298 · Cited by 2
Decoding neuroinflammation: the critical role of NLRP3 inflammasome in Alzheimer’s disease
Chaudhary, B. N., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02274-7 · Cited by 2
Self-citationZhang, C., Song, T., Zhou, J., Wang, X., Rao, X., 丁铲, Cao, H., Jiang, Z., Li, Y. X., Xu, H., et al. (2026) · Environment International · doi:10.1016/j.envint.2026.110373 · Cited by 2
HMGB1 signalling in Alzheimer’s disease: pathogenic roles and therapeutic prospects
Tyagi, P., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., Medhi, B., & HariKrishnaReddy, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117204 · Cited by 2
Self-citationXu, J., Chen, Y., Shi, Y., Sun, A., Yang, Y., Boustani, M. A., Su, J., & Zhang, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231286 · Cited by 2
Novel Emerging Targets Identification in Reducing Risk of Alzheimer’s Disease
Sharma, S., Rahate, K., & Kumar, R. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249333381241012073557 · Cited by 2
Castolo-Sanchez, S., Zamilpa, A., Herrera-Ruiz, M. L., Trejo‐Espino, J. L., Domínguez-Mendoza, B. E., González‐Cortazar, M., & Trejo‐Tapia, G. (2024) · Pharmaceuticals · doi:10.3390/ph17111534 · Cited by 2
Egln3 expression in microglia enhances the neuroinflammatory responses in Alzheimer’s disease
Guan, J., Wu, P., Liu, M., Jiang, C., Meng, X., Wu, X., Lu, M., Fan, Y., & Gan, L. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.022 · Cited by 3
Agustini, D., Sabloak, R., Hasan, S., & Umar, T. P. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100041 · Cited by 2
Wang, Y., Wu, Z., Zheng, Y., Wang, H., Cheng, B., & Xia, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251329517 · Cited by 2
Khan, K. A., Esa, M., Kamal, Z., Ullah, B., Perry, G. L., Kamal, S., Ahmad, S., Hussain, H., Ullah, A., & Shafique, M. S. (2025) · Current Neuropharmacology · doi:10.2174/011570159x361867250313073624 · Cited by 2
Zhang, X., Zhou, J., Wu, H., & Guo, Y. (2025) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2025.2519867 · Cited by 3
Yu, X., Zhou, J., Wang, S., Lü, Y., Gu, Y., & Wang, X. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05266-w · Cited by 2
Nanomicelles of taurine inhibit the fibrillation and toxicity of amyloid β1-42 peptide
Gomes-da-Silva, N. C., Soares, M. A. G., Ricci‐Júnior, E., Amorim, M. D. S. D. N., Alencar, L. M. R., Bhattarai, P., Zhu, L., Follmer, C., & Santos‐Oliveira, R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104721 · Cited by 3
Mapping Alzheimer’s disease: exploring cellular vulnerability and resilience
Ortí-Casañ, N., Bethea, J. R., & Eisel, U. L. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02014-9 · Cited by 1
Progress of Chinese Medicine in Regulating Microglial Polarization against Alzheimer’s Disease
Yang, F., Gao, W., Wang, J. Z., Li, X., & Li, H. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500873 · Cited by 1
Du, Y., Zhang, M., Chen, M., Hu, M., Zeng, W., Cai, X., Zhang, W., Zhu, J., Zhong, M., Liu, Y., et al. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2487140 · Cited by 1
Wu, H., Song, Z., Chen, Q., Yan, R., Zhao, H., & Li, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118037 · Cited by 1
Pa, C., Shen, S., Dai, Y. L., & Wu, M. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1614132 · Cited by 2
Sirtuin1: A Potential Key Regulator in Alzheimer's Disease Pathophysiology and Therapeutics
Chandola, P., Jain, S., Sharma, P., Jamali, M. C., Dwivedi, J., & Sharma, S. K. (2025) · Current Enzyme Inhibition · doi:10.2174/0115734080366376250630054928 · Cited by 1
Chen, W., Huang, Q.-Y., Sun, J.-H., Yang, X., Pei, H., Cao, Y., Li, H., & Ma, L. (2025) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2025.2539987 · Cited by 1
Shi, C., Zhou, Y., Zhang, Q., Jin, W., & Dong, H. (2025) · Mediators of Inflammation · doi:10.1155/mi/4288671 · Cited by 1
He, Q., Yu, H. Q., Zhou, X., Yang, K., Xiao, W., Gao, Z., & He, Q. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1593188 · Cited by 2
Sonwani, A., Pathak, A., & Jain, K. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2576463 · Cited by 1
Zhang, Y., Hou, S., Li, J., Wang, W., Jia, S., Wang, X., Xia, Y., & Wang, Y. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70019 · Cited by 1
Ahmad, H. A., Zafar, M., Khan, T., & Khan, M. I. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05505-1 · Cited by 1
Metadata
- Authors
- Dhapola, R., Hota, S. S., Sarma, P., Bhattacharyya, A., Medhi, B., & Reddy, D. H.
- Affiliations
- Central University of Punjab (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- Government Medical College and Hospital (IN)
- Venue
- Inflammopharmacology
- Published
- 2021-11-23
- Volume
- 29
- Issue
- 6
- Pages
- 1669-1681
- ISSN
- 0925-4692 (ISSN-L)
- 1568-5608
- PMC
- PMC8608577
- OpenAlex
- W3215739089
- Cited by
- 383
- References
- 61
- Citations by year
- 2026: 72 · 2025: 116 · 2024: 111 · 2023: 55 · 2022: 27
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Inflammopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, microglia, amyloid-beta, NF-κB, TNF-α, interleukin-6, p38 MAPK, caspases, nitric oxide, COX-2 inhibitors, PPARγ agonists, pioglitazone, celecoxib, rofecoxib, indomethacin, mitophagy, astrocytes
- MeSH terms
- Neuroinflammatory Diseases, Alzheimer Disease, Animals, Humans, Inflammation, Mitochondria, Cytokines, Inflammation Mediators, Molecular Targeted Therapy, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
